AVITA Medical Affirms FY2026 Sales Guidance of $80.000M-$85.000M vs $82.258M Est

Benzinga Newsdesk www.benzinga.com Negative 77.6%

Neg 77.6% Neu 0% Pos 0%

AVITA Medical (NASDAQ:RCEL) affirms FY2026 sales outlook from $80.000 million-$85.000 million to $80.000 million-$85.000 million vs $82.258 million estimate.